Efficacy and safety of etravirine (TMC125) in treatment-experienced HIV-1-infected patients: 48-week results of a phase IIb trial

Calvin J. Cohen, Daniel S. Berger, Gary Blick, Howard A. Grossman, Dushyantha T. Jayaweera, Peter Shalit, Melanie Thompson, Monika Peeters, Marie Pierre De Béthune, Ellen Voorspoels, Rebecca Mack, Brian Woodfali

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint Dive into the research topics of 'Efficacy and safety of etravirine (TMC125) in treatment-experienced HIV-1-infected patients: 48-week results of a phase IIb trial'. Together they form a unique fingerprint.

Medicine & Life Sciences